In this study, we find that SATB1 is also highly expressed in ovarian cancer cells and lymphoma cells, and importantly SATB1-specific T cells can recognize and kill these cancer cells, suggesting that identification of SATB1 as a tumor antigen has important implications for the development of potentially therapeutic vaccines against ovarian cancer, lymphoma and other types of cancer as well. Here, SATB1 is linked to lymphoma.